Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis
NCT02055534 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144
Last updated 2025-05-01
Summary
Poor nutritional status is common in patients with systemic immunoglobulin light-chain (AL) amyloidosis and has been associated with mortality and impaired quality of life (QoL). We investigated whether nutritional counseling is beneficial to the maintenance of nutritional status and QoL in AL outpatients.
Conditions
- Amyloidosis
Interventions
- OTHER
-
Nutritional counseling
Nutritional counseling consists in: personalized dietary prescription associated with regular (every 3 weeks) dietetic advise by a registered dietician. Follow-up evaluations take place also during the visits scheduled by the oncologists
- OTHER
-
General dietary advices
General dietary advices are provided. Follow-up evaluations take place during the visits scheduled by the oncologists
Sponsors & Collaborators
-
Fondazione IRCCS Policlinico San Matteo di Pavia
lead OTHER
Principal Investigators
-
Riccardo Caccialanza, MD · Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Italy
-
Giampaolo Merlini, MD · Amyloidosis Research and Treatment Center, Biotechnology Research Laboratories, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Italy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- Italy
Study Locations
More Related Trials
-
Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study
NCT02366052 ·Status: COMPLETED ·Phase: PHASE2
-
Parenteral Lipid Emulsions and the Liver Function
NCT03044639 ·Status: COMPLETED ·Phase: PHASE4
-
Omegaven® as Parenteral Nutrition
NCT02334293 ·Status: UNKNOWN ·Phase: NA
-
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
NCT04238416 ·Status: COMPLETED ·Phase: PHASE1
-
Malnutrition in Chronic Pancreatitis, Trans-sectoral Study
NCT04476056 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver Disease
NCT01284049 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
NCT04147936 ·Status: COMPLETED ·Phase: NA
-
Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition
NCT04051840 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
NCT00004347 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Physical Properties of Lipid Emulsions on Gastrointestinal Function
NCT01253005 ·Status: COMPLETED ·Phase: NA
-
Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids
NCT00328159 ·Status: COMPLETED ·Phase: NA
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
NCT06538077 ·Status: RECRUITING ·Phase: PHASE4
-
SMOFLipid in Patients Who Are Intralipid Intolerant
NCT03054948 ·Status: WITHDRAWN ·Phase: PHASE4
-
Breath and Blood Ammonia Response to an Oral Protein Challenge
NCT02650245 ·Status: COMPLETED ·Phase: NA
-
Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury
NCT02780193 ·Status: APPROVED_FOR_MARKETING
-
Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
NCT01223742 ·Status: COMPLETED ·Phase: NA
-
Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life
NCT01008293 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Psyllium (Plantago Ovata) on Digestive Disorders in Familial Amyloidosis
NCT04695340 ·Status: WITHDRAWN ·Phase: NA
-
Cholestasis Reversal: Efficacy of IV Fish Oil
NCT00910104 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Prospective Study of EUS Guided Celiac Block
NCT00583271 ·Status: COMPLETED
-
Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.
NCT05093218 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis.
NCT02265328 ·Status: COMPLETED ·Phase: PHASE2
-
Enteral Nutrition Product in Mild Acute Pancreatitis
NCT01249963 ·Status: UNKNOWN ·Phase: NA
-
Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury
NCT02010034 ·Status: COMPLETED ·Phase: NA